<SEC-DOCUMENT>0001193125-17-123681.txt : 20170414
<SEC-HEADER>0001193125-17-123681.hdr.sgml : 20170414
<ACCEPTANCE-DATETIME>20170413215204
ACCESSION NUMBER:		0001193125-17-123681
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20170411
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20170414
DATE AS OF CHANGE:		20170413

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CONMED CORP
		CENTRAL INDEX KEY:			0000816956
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		IRS NUMBER:				160977505
		STATE OF INCORPORATION:			NY
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-16093
		FILM NUMBER:		17762015

	BUSINESS ADDRESS:	
		STREET 1:		525 FRENCH ROAD
		CITY:			UTICA
		STATE:			NY
		ZIP:			13502
		BUSINESS PHONE:		315-624-3215

	MAIL ADDRESS:	
		STREET 1:		525 FRENCH ROAD
		CITY:			UTICA
		STATE:			NY
		ZIP:			13502
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d379079d8k.htm
<DESCRIPTION>8-K
<TEXT>
<HTML><HEAD>
<TITLE>8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM 8-K
</B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>CURRENT REPORT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>PURSUANT
TO SECTION 13 OR 15 (d)&nbsp;OF THE </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES EXCHANGE ACT OF 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Date of Report (Date of earliest event reported): April&nbsp;11, 2017 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>CONMED CORPORATION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact name of registrant as specified in its charter) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="75%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>New York</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>0-16093</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>16-0977505</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"><B>(State or other jurisdiction of</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>(Commission</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>(I.R.S. Employer</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"><B>incorporation or organization)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>File Number)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>Identification No.)</B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>525 French Road </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Utica, New York 13502 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Address of principal executive offices, including zip code) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(315) 797-8375 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Registrant&#146;s telephone number, including area code) </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the
following provisions (See General Instruction A.2 below): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </TD></TR></TABLE> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section 8.01&nbsp;&nbsp;&nbsp;&nbsp;Other Events </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On April&nbsp;11, 2017, CONMED Corporation (&#147;CONMED&#148;) issued a press release announcing a jury verdict finding CONMED&#146;s
subsidiary, SurgiQuest, liable for $2.2 million in compensatory damages with an additional $10.0 million in punitive damages. As previously disclosed, SurgiQuest became a subsidiary of CONMED on January&nbsp;4, 2016, at which time CONMED assumed the
costs and liabilities related to a previously pending lawsuit with Lexion Medical LLC, subject to the terms of the merger agreement.&nbsp;The underlying claims were that SurgiQuest had engaged in false advertising under the Lanham Act, and had
engaged in violations of Delaware state laws, including deceptive trade practices and unfair competition.&nbsp;Lexion sought damages of&nbsp;$22.0 million&nbsp;in compensatory damages for its alleged lost profits and&nbsp;$18.7 million&nbsp;for
costs related to alleged &#147;corrective advertising&#148; as well as an unspecified sum for disgorgement of SurgiQuest&#146;s alleged profits.&nbsp;The jury awarded compensatory damages of $2.2 million and punitive damages of $10.0&nbsp;million.
The Court entered judgment on April&nbsp;13, 2017. A copy of the press release is attached as Exhibit 99.1 hereto and is incorporated by reference herein. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item 9.01&nbsp;&nbsp;&nbsp;&nbsp;Financial Statements and Exhibits. </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top">Exhibits </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following exhibit is included herewith: </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="85%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD WIDTH="91%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:39.10pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit&nbsp;No.</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:75.45pt; font-size:8pt; font-family:Times New Roman"><B>Description of Exhibit</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.50em; text-indent:-2.50em; font-size:10pt; font-family:Times New Roman">Press&nbsp;&nbsp;Release dated April&nbsp;11, 2017, issued by CONMED Corporation.</P></TD></TR>
</TABLE> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Signature </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned
thereunto duly authorized. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="12%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">CONMED CORPORATION</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Registrant)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Luke A. Pomilio</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Name:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Luke A. Pomilio</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Title:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Executive Vice President-Finance and</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Chief
Financial Officer</P></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date: April&nbsp;13, 2017 </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT INDEX </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="93%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>Exhibit</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; width:28.45pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:66.80pt; font-size:8pt; font-family:Times New Roman"><B>Exhibit Description</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Press Release, dated April 11, 2017, issued by CONMED Corporation.</TD></TR>
</TABLE> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d379079dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt; margin-left:6%; text-indent:-6%">


<IMG SRC="g379079g0413154755453.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:11%; text-indent:-11%; font-size:18pt; font-family:Times New Roman"><B>NEWS RELEASE </B></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="35%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>CONTACT:</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>CONMED
Corporation</I></B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Luke A. Pomilio</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Chief Financial
Officer</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">315-624-3202</FONT></FONT></B></P></TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>CONMED Corporation Announces Jury Verdict </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>in Delaware Litigation Against SurgiQuest </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Utica, New York, April</B><B></B><B>&nbsp;11, 2017 &#150; CONMED Corporation (NASDAQ: CNMD)</B> today announced that a jury in the United State Federal
District Court for the District of Delaware returned a verdict finding CONMED&#146;s subsidiary, SurgiQuest, liable for $2.2&nbsp;million in compensatory damages with an additional $10.0&nbsp;million in punitive damages. The jury verdict relates to
the litigation between SurgiQuest and Lexion Medical LLC that CONMED acquired in connection with its acquisition of SurgiQuest, as disclosed in CONMED&#146;s Form <FONT STYLE="white-space:nowrap">10-K</FONT> dated February&nbsp;27, 2017. The
litigation first began in 2013, prior to CONMED&#146;s acquisition of SurgiQuest in January 2016. The underlying claims are that SurgiQuest previously engaged in false advertising in marketing literature related to the AirSeal<SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP><SUP STYLE="font-size:85%; vertical-align:top"> </SUP>system. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;While we are disappointed in the
jury&#146;s verdict, we intend to pursue all post-trial and appellate remedies,&#148; said Daniel S. Jonas, Esq., CONMED&#146;s Executive Vice President, Legal Affairs and General Counsel. &#147;This litigation will have no impact on the
availability of, or CONMED&#146;s ability to distribute, our innovative AirSeal<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> access port or the AirSeal<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> IFs unit.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;While we respect the jury&#146;s verdict, this litigation does not take away from the outcomes experienced by the surgeons who have used the AirSeal<SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP> in more than 600,000 surgeries to date. These products are the most technologically advanced and provide the only integrated access management system for robotic and laparoscopic surgery on the
global market,&#148; said Curt R. Hartman, CONMED&#146;s President and Chief Executive Officer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About CONMED Corporation </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CONMED is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. The Company&#146;s products are used by
surgeons and physicians in a variety of specialties, including orthopedics, general surgery, gynecology, neurosurgery and gastroenterology. CONMED has a direct selling presence in 17 countries and international sales constitute approximately 50% of
the Company&#146;s total sales. Headquartered in Utica, New York, the Company employs approximately 3,300 people. For more information, visit <U>www.conmed.com</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward Looking Statements </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This press release
contains forward-looking statements based on certain assumptions and contingencies that involve risks and uncertainties, which could cause actual results, performance, or trends to differ materially from those expressed in the forward-looking
statements herein or in previous disclosures. For example, in addition to general industry and economic conditions, factors that could cause actual results to differ materially from those in the forward-looking statements may include, but are not
limited to, the risk factors discussed in the Company&#146;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;31, 2016. Any and all forward-looking statements are made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act of 1995 and relate to the Company&#146;s performance on a going-forward basis. The Company believes that all forward-looking statements made by it have a reasonable basis, but there
can be no assurance that management&#146;s expectations, beliefs or projections as expressed in the forward-looking statements will actually occur or prove to be correct. </I></P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g379079g0413154755453.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g379079g0413154755453.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !  .\# 2(  A$! Q$!_\0
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M&].\*Z+#I>F0B.&,?,V/FD;NS'N36?\ $+0KGQ)X&U/3+0C[1+%F,'^(CG%
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MK^J+HGA^_P!389%M T@'J0./UK1KG_&B6]WX6OM,EN8X9KV%H85=L%W(X H
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MT 2^ O$T?BSP=8:HI'FM&$F4'[L@X8?G7E7Q+GF^(/Q2TKP/9.39V;[[QE/
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,'-='10 4444 ?__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
